Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dff902f580792a5b5b5e40f1e29bfd6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-814 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
1991-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20677e0454872598a63dd6fdd116845e |
publicationDate |
1993-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0565541-A1 |
titleOfInvention |
Diagnostic method for detecting the rupture of fetal membranes and test kit employing the method |
abstract |
Rapid and reliable diagnostic method for detecting a rupture of the fetal membranes and test kit for carrying out said method. The presence of insulin-like growth factor-binding protein 1 (IGFBP-1), which results from the rupture of the fetal membranes, is detected in a vaginal secretion sample, thanks to a specific IGFBP-binding substance. -1. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709272-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10656164-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11353464-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011151597-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114610-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10422802-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10935555-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2960974-A1 |
priorityDate |
1990-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |